Biotech News

Integra LifeSciences Welcomes Policy Advancements Supporting Medicare Beneficiary Access

Integra LifeSciences (IART)Integra LifeSciences2025-11-25 13:30 ESTCompany update

Company to advance care through broader access to breadth of skin substitutes across four unique technology platforms PRINCETON, N.J., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, commends the Centers for

Integra LifeSciences

Medical Technology Portfolio Integra LifeSciences develops medical technologies used in neurosurgery, reconstructive surgery and wound care. Its products support procedures in which tissue protection, repair and regeneration are critical to patient outcomes. Neurosurgical Technologies The company supplies instruments, implants and...

Recent company news

IARTIntegra LifeSciences2026-07-29 10:00 EST

Stock data

Close: 16.74 USD
Market cap: 1.22B USD
Exchange: NASDAQ
Sector: Biopharma
Location: United States

Integra LifeSciences Welcomes Policy Advancements Supporting Medicare Beneficiary Access

Related news

Integra LifeSciences Reports Second Quarter 2026 Financial Results

Integra LifeSciences to Host Second Quarter 2026 Financial Results Conference Call on July 29, 2026

CVRx Announces Devoted Health Medicare Advantage Coverage Policy for Barostim Therapy

IceCure Highlights Two New Peer-Reviewed Publications Supporting Cryoablation in Breast Cancer Treatment De-Escalation

Integra LifeSciences

Recent company news

Integra LifeSciences Reports Second Quarter 2026 Financial Results

Integra LifeSciences to Host Second Quarter 2026 Financial Results Conference Call on July 29, 2026

Integra LifeSciences Appoints Topaz Kirlew Chief Regulatory Officer

Integra LifeSciences Announces Key Executive Appointments

Integra LifeSciences to Present at the 2026 Truist Securities MedTech Conference

Stock data